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Standard ocular tumor treatment includes brachythera-
py, as well as proton therapy, particularly for large mela-
noma tumors. However, the effects of different radiation 
types on the metastatic spread is not clear. We aimed at 
comparing ruthenium (106 Ru, emitting β electrons) and 
iodine (125I, γ-radiation) brachytherapy and proton beam 
therapy of melanoma implanted into the hamster eye on 
development of spontaneous lung metastases. Tumors 
of Bomirski Hamster Melanoma (BHM) implanted into 
the anterior chamber of the hamster eye grew aggres-
sively and completely filled the anterior chamber within 
8–10 days. Metastases, mainly in the lung, were found 
in 100% of untreated animals 30 days after enucleation. 
Tumors were irradiated at a dose of 3–10 Gy with a 106Ru 
plaque and at a dose of 6–14 Gy using a 125I plaque. The 
protons were accelerated using the AIC-144 isochronous 
cyclotron operating at 60 MeV. BHM tumors located in 
the anterior chamber of the eye were irradiated with 10 
Gy, for the depth of 3.88 mm. All radiation types caused 
inhibition of tumor growth by about 10 days. An in-
crease in the number of metastases was observed for 
3 Gy of β-irradiation, whereas at 10 Gy an inhibition of 
metastasis was found. γ-radiation reduced the metastatic 
mass at all applied doses, and proton beam therapy at 
10 Gy also inhibited the metastastic spread. These re-
sults are discussed in the context of recent clinical and 
molecular data on radiation effects on metastasis.
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InTRoduCTIon
Particle radiotherapy, such as proton beam, yields 
promising clinical results worldwide, but the mechanisms 
of its action are still unclear. Ocular melanoma is one 
of the tumors treated by protons with excellent clinical 
results (Fuss et al., 2001; Höcht et al., 2004; Gragoudas, 
2006;). The advantage of particle beams over photons is 
due to the physical characteristics and results in superior 
distribution of the radiation dose, which allows to spare 
normal tissue close to the target (Levin et al., 2005; Fokas 
et al., 2009). Proton beam therapy is also applied in other 
cancer treatments (Mizumoto et al., 2010; Mizumoto et 
al., 2011; Lorentini et al., 2012). However, the effects of 
particle beams on metastatic spread of cancer are not yet 
well understood. There are only a few publications on 
this subject. It was shown that particle beams might in-
hibit cellular metastatic potential (Takahashi et al., 2003). 
Proton ion irradiation was also demonstrated to decrease 
cell migration and invasion in a dose-dependent manner 
and strongly inhibit matrix metaloproteinase-2 activity in 
two preclinical models (Ogata et al., 2005). These results 
suggest that particle irradiation suppresses metastatic po-
tential at a low dose, whereas another report shows that 
photon irradiation promotes cell migration and invasive 
capabilities at a low dose level.
Enhancement of migratory properties of different 
tumor cell lines were found after 1-3 Gy of gamma 
irradiation (Wild-bode et al., 2001; Goetze et al., 2010). 
Several factors associated with increased migratory 
properties have been found to be induced by gamma 
irradiation, such as HGF receptor/c-Met expression 
(Qian et al., 2003), integrin expression (Onoda et al., 
1992; Goetze et al., 2010) or MMP-2 activity (Wild-
bode et al., 2001, Park et al., 2006; Martinou et al., 
2011). In particular there are suggestions that it is the 
interaction with tumor microenvironment that influ-
ences cell migration and invasiveness (Ohuchida 2004; 
Madani et al., 2008).
These findings taken together indicate that ion beam 
radiotherapy may be superior to conventional photon 
beam therapy in possible preventive effects on tumor 
cell metastasis (Girdhani et al., 2013). In our animal 
model we can observe both immediate effects, such as 
inhibition of the growth of the radiation treated tumor, 
and long- term effects of the therapy, such as reduction 
in the number of metastases (Urbanska et al., 2000; Ma-
tuszak et al., 2000).
The goal of this study was to compare the effects of 
β- and γ-radiation using brachytherapy and proton beam 
radiation of melanoma tumor growing in the eye on the 
development of metastases in the lung. In this study we 
show, for the first time, a substantial inhibition of lung 
metastasis after a single dose of 10 Gy (ie. 11.1 CGE 
Cobalt Grey Equivalent) of proton beam irradiation of 
the melanoma tumor growing in the hamster eye.
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MATeRIAlS And MeTHodS
Animals and tumors. The total of 60 female ham-
sters, weighting 80–120g, derived from the breeding 
facility at the University of Silesia, Katowice, Poland, 
were maintained on the standard laboratory diet with 
free access to drinking water. The study was per-
formed in compliance with European policies and 
was approved by the Bioethics Committee for Animal 
Experiments (no 280/96, 384/99 and 35/2011 from 
April 20th 2011). A spontaneous skin melanoma, 
Bomirski Hamster Melanoma (Bomirski et al., 1988), 
was used as a tumor model. Tumor implantation was 
performed as described earlier (Kukielczak et al., 1999; 
Urbanska et al., 2000; Romanowska-Dixon et al., 2001; 
Romanowska-Dixon et al., 2003). Briefly, tumor frag-
ments were implanted microsurgically into the anterior 
chamber of the hamster eye. Six to nine days later 
tumors were visible, growing in the anterior chamber 
on the surface of the iris as well demarcated, dome-
shaped single nodules. To non-invasively monitor the 
tumor growth in the hamster eye in vivo we estimated 
two dimensions of the tumor on the surface of the 
iris, applying a microscopic ruler. This approach as-
sumes that assessment of only two dimensions in the 
plane of the iris reflects tumor growth adequately, as 
the growth in the depth dimension is limited by the 
anterior chamber volume. Two perpendicular diam-
eters “a” and “b” of the tumor were measured each 
day and the mean tumor dimension was calculated 
(√a×b) in mm. Eyeballs were enucleated when the an-
terior chamber was completely filled with the tumor. 
Thirty days after the enucleation animals were sacri-
ficed, and internal organs were examined for metasta-
ses, clearly visible as black dots. Lungs were isolated 
and weighted.
Brachytherapy. Tumors were irradiated at a dose 
of 3, 6 and 10 Gy with a 106Ru plaque (model Rue.
EBB, 11.8 Mbq, BEBIG GmbH, Germany) at 0.017 
Gy/min and with a 125I plaque (BEBIG GmbH, Ger-
many) at 0.012 Gy/min. All radiation exposures were 
preceded by injections of Vetbutal (36 mg/kg body 
weight). Doses were fractionated into 4 equal fractions 
administered every 24 hrs. The time of irradiation for 
a single fraction was from 62 to 294 min. 106Ru emit-
ted electrons have the energy of 3.54 MeV and 125I is 
a source of γ-rays with the energy of 35.4 keV.
Proton beam. Protons for the irradiation experiments 
were accelerated using the AIC-144 isochronous cyclo-
tron, operating at 60 MeV, which was designed and con-
structed at IFJ PAN (Kraków, Poland). The beam de-
livery system, the formation of a primary proton beam, 
was described by Bakewicz and Swakon (Bakewicz et al., 
2003; Swakon et al., 2010).
The proton beam had to be specially formed for 
the irradiation purposes. The uniform lateral dose 
distribution was realized by a passive scattering with 
single tantalum foil (Swakon et al., 2010, Michalec et 
al., 2010). The Spread Out Bragg Peak (SOBP) was 
formed by a dedicated rotating modulator wheel, made 
of PMMA. The proton beam range was controlled by 
a PMMA range shifter or a set of PMMA plates with 
different thickness.
For the irradiation of hamster eyeballs the pro-
ton beam was configured to irradiate only the ante-
rior chamber of the hamster eye. The proton beam 
has been prepared to penetrate the tissue to a depth 
of 3.88 mm (4.07 mm in water). The diameter of the 
final collimator was equal to 7 mm in order to irra-
diate only the eyeball area with a small margin. The 
transversal profiles were measured in air using a one 
dimensional scanner with diode and presented in the 
inset of Fig. 1C.
The proton beam monitoring system and the 
beam dosimetry. The set of ion chambers with dedi-
cated Ergen electrometers was used for monitoring the 
proton beam parameters. The proton beam intensity 
has been measured by two PTW transmission ionization 
chambers type 7862. During irradia-
tion the type 7862 ionization cham-
bers carried out the function of a 
dose monitor. The time and spatial 
stability of the beam was controlled 
on-line by a six sector dedicated ion 
chamber, which consisted of four 
ion chambers in the form of quar-
ters, a circle ion chamber and a ring 
one.
The PTW UNIDOS electrom-
eter and the Markus chamber 
PTW type 23343 have been used 
to calibrate the dose. Dose meas-
urements were performed in the 
middle of SOBP using the solid 
phantom (PMMA). Overall un-
certainty of dosimetry was about 
3%, the precision of dose delivery 
was better than 0.5%. The average 
dose rate of the proton beam dur-
ing irradiation was between 0.07 
and 0.08 Gy/s.
Hamster eye positioning and 
proton beam irradiation. Pri-
or to the animal experiments, a 
phantom of the hamster head was 
used to develop the animal posi-
tioning system and hamster eye 
positioning. The analysis took into 
Figure 1. Hamster eye irradiation with proton beam. 
(A) Hamster in the animal positioning system, (B) hamster eye with the tumor, magnifica-
tion 10x and (C) proton beam dose depth distribution and lateral profiles of the beam 
used for hamster eye irradiation.
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account the protruding 
shape of the hamster eye 
and the size of the ante-
rior chamber. The animal 
positioning system con-
sisted of an animal hold-
er, attached to the frame 
of the 3D positioning sys-
tem, movable at 0.01 mm 
steps. A laser positioning 
subsystem and entrance 
field simulation light have 
been used for an accurate 
hamster eye positioning in 
the proton beam.
A single dose of 10 Gy 
(11 CGE) has been deliv-
ered within a maximum 
irradiation time of 150 
s. Animals were anesthe-
tized for about 30 min, 
for both the positioning 
and irradiation, using 100 
mg/kg ketamine (Bioket-
an, Vetoquinol, Biowet, 
Poland) and 10 mg/kg 
xylazine (Sedazin, Biowet, 
Poland).
Statistical analysis. The 
significance of the differ-
ence between the experi-
mental groups was deter-
mined using Student t-test, 
with p < 0.05.
ReSulTS And 
dISCuSSIon
Growth inhibition of the primary tumor
125I irradiation led to inhibition of the tumor growth 
in the eye from 7 days in untreated animals to 14–17 
days in animals irradiated with fractionated doses be-
tween 6–14 Gy (Fig. 2A). 106Ru brachytherapy did not 
affect the primary tumor growth (data not shown). After 
several days, some regrowth of the primary tumor was 
observed. The inhibition after γ-radiation was similar to 
that achieved after 10 Gy of proton beam irradiation 
(Fig. 3B). It has to be pointed out that different radia-
tion dose rates have been used: 0.017 Gy/min for 106Ru, 
0.012 Gy/min for 125I and 4.2 Gy/min for proton beam 
irradiation. Therefore a direct comparison of the effects 
is not possible.
enhancement of metastasis by very low doses of beta-
radiation
Treatment with γ-irradiation strongly inhibited meta-
static spread, as seen in Fig. 2B, however, it seems that 
the lowest dose of 3 Gy of β-radiation caused an increase 
in lung metastasis. The largest applied dose of 10 Gy of 
β-radiation led to inhibition of metastasis (Fig. 2C).
Our previous studies have shown that BHM mela-
noma growing in the hamster eye is heavily vascular-
ized, and that this vascular network is highly patho-
logical, with densely distributed, tortuous, and ir-
regular vessels, with many sprouts and embolisms 
(Romanowska-Dixon et al., 2001). One may speculate 
Figure 2. The effects of γ- and β-irradiation of the BHM melanoma tumor growing in the hamster 
eye. 
(A) Growth inhibition of primary tumor implanted in the eye by 125I irradiation. (B) Inhibition of lung 
metastasis after a fractionated dose of 6-14 Gy of 125I irradiation of BHM melanoma tumors growing 
in the hamster eye. (C) 106Ru slightly affected tumor growth in the eye. (D) The effect of fractionated 
doses of 106Ru irradiation on lung metastasis. The experimental group consisted of 5–8 of animals. 
Asterisks indicate statistical significance of p < 0.05 in comparison with control.
Figure 3. (A) Inhibition of BHM melanoma tumor growing in the 
hamster eye, irradiated with a proton beam at a single dose 
of 10 Gy (n = 7, black square), in comparison with untreated 
control (n = 6, black diamond). (B) The mass of metastases to 
the lung decreased 4.35 times after proton beam irradiation 
(10 Gy) of BHM melanoma tumor growing in the hamster eye 
(p = 0.0052). Average mass with SeM is shown. The number of 
control animals was 6, and the number of irradiated animals 
was 7. Representative isolated lungs with metastases from un-
treated (C) and irradiated (D) animals.
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that irradiation of such tissue will lead to destruction 
of endothelial cells, and subsequently to leakage of 
vasculature, thus promoting metastatic spread. One of 
the mechanisms involved in the endothelial cell death 
after radiation is activation of the ceramide-sphingo-
myelin pathway, although usually induced at the lev-
el of 10 Gy dose (Kolesnick & Fuks, 2003; Fuks & 
Kolesnick, 2005).
The clinical reports justifying the use of short-range 
electron emitting brachytherapy did not demonstrate any 
enhancement of metastasis (Lommatzsch et al., 2000). 
There was a suggestion, however, to treat patients with 
possibly low dose-rate plaques (Kleineidam & Guthoff 
1994). The randomized trial of 125I brachytherapy did 
not find any differences in the metastasis rates (COMS 
2006).
Inhibition of metastasis by proton beam irradiation of 
the primary tumor
A single dose of 10 Gy of proton beam irradia-
tion delayed the growth of the BHM melanoma in 
the hamster eye by 10 days (Fig. 3B). Albeit the in-
hibition of the primary tumor growth was moderate, 
proton therapy strikingly reduced the mass of the me-
tastases in the lungs in comparison with untreated an-
imals. On average, 10 Gy of proton irradiation dimin-
ished the mass of metastases 4.35 times, even though 
there was a significant spread between individual ani-
mals (Fig. 3A, C, D). These results are in agreement 
with data for osteosarcoma published by Ogata et al. 
(2005). Proton ion irradiation decreased cell migra-
tion and invasion in a dose-dependent manner and 
strongly inhibited matrix metaloproteinase-2 activity in 
highly aggressive HT1080 human fibrosarcoma cells in 
vitro and significantly decreased the number of pulmo-
nary metastases in mouse osteosarcoma in vivo (Ogata et 
al., 2005). Similarly, it was shown that in in vitro mod-
els cell properties such as adhesion, migration, inva-
sion, and the expression level or activity of molecules 
related to metastasis such as αVβ3, β1 integrin, and 
MMP-2 were decreased after small doses of proton 
beam treatment (Takahashi et al., 2003).
Suppression of the growth of spontaneous metas-
tases observed after proton beam therapy in hamsters 
may stem from numerous mechanisms, such as inhibi-
tion of cell motility, adhesion, and invasion, or pertur-
bation of cell death pathways. To fully address these 
issues, we will continue to study these mechanisms on 
the cellular, molecular and submolecular level.
ConClusions
1. Small, sublethal doses of β-irradiation might in-
crease the metastatic spread.
2. Proton beam irradiation at 10 Gy inhibited the 
growth of melanoma tumor in the hamster eye and di-
minished number of metastases in the lung more than 
four times.
3. The already established infrastructure (modern-
ized AIC-144 cyclotron, the beam delivery system, the 
therapy room) as well as the equipment for the beam 
control and monitoring and the human eye position-
ing systems, prepared for treatment of human pa-
tients, were adapted and developed for irradiation of a 
very small, 4–6 mm in diameter, hamster eye.
4. The mechanisms of tumor growth inhibition after 
proton beam irradiation need further explanation.
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